AstraZeneca Purchases 692,000 SF Amgen Facility in Longmont
View here AstraZeneca, a global, science-led biopharmaceutical firm, spent $64.5M on a manufacturing plant that sits on a 228-acre site in Longmont from Amgen, Inc. Image extracted from AstraZeneca R&D Image Library
AstraZeneca Purchases 692,000 SF Amgen Facility in Longmont Read More »










